The role of activated coagulation factor XII in overall clot stability and fibrinolysis

Thrombosis Research

Volumn 136, Issue 2, 2015, Pages 474-480

  Konings, Joke ^a   Hoving, Lisa R ^a   Ariëns, Robert S ^b   Hethershaw, Emma L ^b   Ninivaggi, Marisa ^a   Hardy, Lewis J ^b   De Laat, Bas ^a   Ten Cate, Hugo ^a   Philippou, Helen ^b   Govers Riemslag, José W P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Blood coagulation; Clot structure; Coagulation factor XII; Fibrin(ogen); Fibrinolysis; Tissue plasminogen activator (tPA)

Indexed keywords

ALPHA BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 12A; FIBRIN; PLASMIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; EUGLOBULIN LYSIS TEST; FIBRIN CLOT; FIBRIN FORMATION; FIBRINOLYSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE AREA; BLOOD CLOTTING TIME; HUMAN; METABOLISM; PHYSIOLOGY;

BLOOD COAGULATION; FACTOR XIIA; FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; WHOLE BLOOD COAGULATION TIME;

EID: 84938553372     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.06.028     Document Type: Article

References (35)

1. M.B. Ponczek, D. Gailani, and R.F. Doolittle Evolution of the contact phase of vertebrate blood coagulation J. Thromb. Haemost. 6 2008 1876 1883
2. R.W. Colman Activation of plasminogen by human plasma kallikrein Biochem. Biophys. Res. Commun. 35 1969 273 279
3. G.H. Goldsmith Jr., H. Saito, and O.S. Ratnoff The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments J. Clin. Invest. 62 1978 54 60
4. R.J. Mandle Jr., and A.P. Kaplan Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen Blood 54 1979 850 862
5. L.A. Miles, J.S. Greengard, and J.H. Griffin A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen Thromb. Res. 29 1983 407 417
6. D.C. Rijken, and H.R. Lijnen New insights into the molecular mechanisms of the fibrinolytic system J. Thromb. Haemost. 7 2009 4 13
7. M. Hoylaerts, D.C. Rijken, H.R. Lijnen, and D. Collen Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin J. Biol. Chem. 257 1982 2912 2919
8. J.W. Weisel Structure of fibrin: impact on clot stability J. Thromb. Haemost. 5 Suppl. 1 2007 116 124
9. E.J. Dunn, H. Philippou, R.A. Ariens, and P.J. Grant Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus Diabetologia 49 2006 1071 1080
10. C. Longstaff, C. Thelwell, S.C. Williams, M.M. Silva, L. Szabo, and K. Kolev The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies Blood 117 2011 661 668
11. N.J. Mutch, R. Engel, S. Uitte de Willige, H. Philippou, and R.A. Ariens Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin Blood 115 2010 3980 3988
12. J. Konings, J.W. Govers-Riemslag, H. Philippou, N.J. Mutch, J.I. Borissoff, P. Allan, and et al. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin Blood 118 2011 3942 3951
13. N.J. Mutch, N.R. Moore, C. Mattsson, H. Jonasson, A.R. Green, and N.A. Booth The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro Br. J. Pharmacol. 153 2008 124 131
14. T. Renne, M. Pozgajova, S. Gruner, K. Schuh, H.U. Pauer, P. Burfeind, and et al. Defective thrombus formation in mice lacking coagulation factor XII J. Exp. Med. 202 2005 271 281
15. A.S. Revenko, D. Gao, J.R. Crosby, G. Bhattacharjee, C. Zhao, C. May, and et al. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding Blood 118 2011 5302 5311
16. P.M. Jansen, R.A. Pixley, M. Brouwer, I.W. de Jong, A.C. Chang, C.E. Hack, and et al. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase Blood 87 1996 2337 2344
17. M. Levi, C.E. Hack, J.P. de Boer, D.P. Brandjes, H.R. Buller, and J.W. ten Cate Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo J. Clin. Invest. 88 1991 1155 1160
18. E.A. Braat, G. Dooijewaard, and D.C. Rijken Fibrinolytic properties of activated FXII Eur. J. Biochem. 263 1999 904 911
19. I. Schousboe, K. Feddersen, and R. Rojkjaer Factor XIIa is a kinetically favorable plasminogen activator Thromb. Haemost. 82 1999 1041 1046
20. A. Tanaka, Y. Suzuki, K. Sugihara, N. Kanayama, and T. Urano Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro Life Sci. 85 2009 220 225
21. D.E. Cool, C.J. Edgell, G.V. Louie, M.J. Zoller, G.D. Brayer, and R.T. MacGillivray Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa J. Biol. Chem. 260 1985 13666 13676
22. L. Medved, and W. Nieuwenhuizen Molecular mechanisms of initiation of fibrinolysis by fibrin Thromb. Haemost. 89 2003 409 419
23. C. Puy, E.I. Tucker, Z.C. Wong, D. Gailani, S.A. Smith, S.H. Choi, and et al. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates J. Thromb. Haemost. 11 2013 1341 1352
24. F. Caiado, T. Carvalho, F. Silva, C. Castro, N. Clode, J.F. Dye, and et al. The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healing Biomaterials 32 2011 7096 7105
25. C.A. Bootle-Wilbraham, S. Tazzyman, W.D. Thompson, C.M. Stirk, and C.E. Lewis Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro Angiogenesis 4 2001 269 275
26. G.A. LaRusch, F. Mahdi, Z. Shariat-Madar, G. Adams, R.G. Sitrin, W.M. Zhang, and et al. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis Blood 115 2010 5111 5120
27. J.A. Cooper, G.J. Miller, K.A. Bauer, J.H. Morrissey, T.W. Meade, D.J. Howarth, and et al. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease Circulation 102 2000 2816 2822
28. C.J. Doggen, F.R. Rosendaal, and J.C. Meijers Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII Blood 108 2006 4045 4051
29. J.W. Govers-Riemslag, M. Smid, J.A. Cooper, K.A. Bauer, R.D. Rosenberg, C.E. Hack, and et al. The plasma kallikrein-kinin system and risk of cardiovascular disease in men J. Thromb. Haemost. 5 2007 1896 1903
30. K. Talbot, S.C. Meixner, and E.L. Pryzdial Enhanced fibrinolysis by proteolysed coagulation factor Xa Biochim. Biophys. Acta 2010 1804 723 730
31. A. Matafonov, P.Y. Leung, A.E. Gailani, S.L. Grach, C. Puy, Q. Cheng, and et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model Blood 123 2014 1739 1746
32. M.J. Kuijpers, P.E. van der Meijden, M.A. Feijge, N.J. Mattheij, F. May, J. Govers-Riemslag, and et al. Factor XII regulates the pathological process of thrombus formation on ruptured plaques Arterioscler. Thromb. Vasc. Biol. 34 2014 1674 1680
33. I. Hagedorn, S. Schmidbauer, I. Pleines, C. Kleinschnitz, U. Kronthaler, G. Stoll, and et al. Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding Circulation 121 2010 1510 1517
34. R.S. Woodruff, Y. Xu, J. Layzer, W. Wu, M.L. Ogletree, and B.A. Sullenger Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer J. Thromb. Haemost. 11 2013 1364 1373
35. M. Larsson, V. Rayzman, M.W. Nolte, K.F. Nickel, J. Bjorkqvist, A. Jamsa, and et al. A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk Sci. Transl. Med. 6 2014 222ra17